Furthermore, immunostaining of tumor samples, including MHCC97H xenografts and PDXs, showed a considerable decrease in GPX4 expression following IR treatment in cases where USP14 was deleted or inhibited in vivo (Fig. 4F, G). This evidence concerns the gene GPX4 and neoplasm.